Skip to main content
Top
Published in: Indian Journal of Surgery 5/2023

16-02-2023 | Colorectal Cancer | Original Article

Prognostic Nomogram for Colorectal Cancer Patients After Surgery

Authors: Pengqiang Zhong, Jiali Wu, Xingxing Yan, Yin Liu, Ruizhi Wang, Dong Wang

Published in: Indian Journal of Surgery | Issue 5/2023

Login to get access

Abstract

To construct a nomogram for overall survival (OS) in colorectal cancer. Using Cox univariate and multivariate analysis, significant variables were plotted into a nomogram. The predictive accuracy and discriminative ability of the nomogram was determined using the concordance index (C-index), receiver operator characteristic curve and calibration curve. CA125 and tumor node metastasis (TNM) were identified as independent predictors for OS in colorectal cancer patients. Area under the curve (AUC) for 1, 3, and 5 years was 0.89, 0.723, and 0.71 respectively in primary cohort, and C-index was 0.702 (95% CI, 0.610 to 0.794) in validation cohort, which indicated a middle degree of accuracy. High-quality calibration plots were seen in the OS nomogram models. Age, CA125, and TNM were identified as poor predictors of colorectal cancer. This nomogram is a valuable predictive tool for the prognosis of colorectal cancer.
Literature
1.
go back to reference Sung H, Ferlay J, Siegel RL et al (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209–249CrossRefPubMed Sung H, Ferlay J, Siegel RL et al (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209–249CrossRefPubMed
2.
go back to reference Carethers JM, Doubeni CA (2020) Causes of socioeconomic disparities in colorectal cancer and intervention framework and strategies. Gastroenterology 158(2):354–367CrossRefPubMed Carethers JM, Doubeni CA (2020) Causes of socioeconomic disparities in colorectal cancer and intervention framework and strategies. Gastroenterology 158(2):354–367CrossRefPubMed
3.
go back to reference Khazaei S, Rezaeian S, Khazaei S et al (2016) Effects of human development index and its components on colorectal cancer incidence and mortality: a global ecological study. Asian Pac J Cancer Prev 17(S3):253–256CrossRefPubMed Khazaei S, Rezaeian S, Khazaei S et al (2016) Effects of human development index and its components on colorectal cancer incidence and mortality: a global ecological study. Asian Pac J Cancer Prev 17(S3):253–256CrossRefPubMed
4.
go back to reference Porcellini E, Laprovitera N, Riefolo M et al (2018) Epigenetic and epitranscriptomic changes in colorectal cancer: diagnostic, prognostic, and treatment implications. Cancer Lett 419:84–95CrossRefPubMed Porcellini E, Laprovitera N, Riefolo M et al (2018) Epigenetic and epitranscriptomic changes in colorectal cancer: diagnostic, prognostic, and treatment implications. Cancer Lett 419:84–95CrossRefPubMed
5.
go back to reference Yamano T, Yamauchi S, Igeta M et al (2020) Combination of preoperative tumour markers and lymphovascular invasion with TNM staging as a cost and labour efficient subtyping of colorectal cancer. Sci Rep 10(1):10238CrossRefPubMedPubMedCentral Yamano T, Yamauchi S, Igeta M et al (2020) Combination of preoperative tumour markers and lymphovascular invasion with TNM staging as a cost and labour efficient subtyping of colorectal cancer. Sci Rep 10(1):10238CrossRefPubMedPubMedCentral
6.
go back to reference Dienstmann R, Mason MJ, Sinicrope FA et al (2017) Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study. Ann Oncol 28(5):1023–1031CrossRefPubMedPubMedCentral Dienstmann R, Mason MJ, Sinicrope FA et al (2017) Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study. Ann Oncol 28(5):1023–1031CrossRefPubMedPubMedCentral
7.
go back to reference Zhang F, Zhang Y, Zhao W et al (2017) Metabolomics for biomarker discovery in the diagnosis, prognosis, survival and recurrence of colorectal cancer: a systematic review. Oncotarget 8(21):35460–35472CrossRefPubMedPubMedCentral Zhang F, Zhang Y, Zhao W et al (2017) Metabolomics for biomarker discovery in the diagnosis, prognosis, survival and recurrence of colorectal cancer: a systematic review. Oncotarget 8(21):35460–35472CrossRefPubMedPubMedCentral
8.
go back to reference Silva A, Faria G, Araújo A et al (2020) Impact of adiposity on staging and prognosis of colorectal cancer. Crit Rev Oncol Hematol 145:102857CrossRefPubMed Silva A, Faria G, Araújo A et al (2020) Impact of adiposity on staging and prognosis of colorectal cancer. Crit Rev Oncol Hematol 145:102857CrossRefPubMed
9.
go back to reference To K K, Tong CW, Wu M et al (2018) MicroRNAs in the prognosis and therapy of colorectal cancer: from bench to bedside. World J Gastroenterol 24(27):2949–2973CrossRefPubMedPubMedCentral To K K, Tong CW, Wu M et al (2018) MicroRNAs in the prognosis and therapy of colorectal cancer: from bench to bedside. World J Gastroenterol 24(27):2949–2973CrossRefPubMedPubMedCentral
10.
go back to reference Barel F, Cariou M, Saliou P et al (2019) Histopathological factors help to predict lymph node metastases more efficiently than extra-nodal recurrences in submucosa invading pT1 colorectal cancer. Sci Rep 9(1):8342CrossRefPubMedPubMedCentral Barel F, Cariou M, Saliou P et al (2019) Histopathological factors help to predict lymph node metastases more efficiently than extra-nodal recurrences in submucosa invading pT1 colorectal cancer. Sci Rep 9(1):8342CrossRefPubMedPubMedCentral
11.
go back to reference Chao G, Ye F, Li T et al (2019) Estimation of invasion depth of early colorectal cancer using EUS and NBI-ME: a meta-analysis. Tech Coloproctol 23(9):821–830CrossRefPubMed Chao G, Ye F, Li T et al (2019) Estimation of invasion depth of early colorectal cancer using EUS and NBI-ME: a meta-analysis. Tech Coloproctol 23(9):821–830CrossRefPubMed
12.
go back to reference Gunnarsson H, Ekholm A, Olsson LI (2013) Emergency presentation and socioeconomic status in colon cancer. Eur J Surg Oncol 39(8):831–836CrossRefPubMed Gunnarsson H, Ekholm A, Olsson LI (2013) Emergency presentation and socioeconomic status in colon cancer. Eur J Surg Oncol 39(8):831–836CrossRefPubMed
13.
go back to reference Haq AI, Schneeweiss J, Kalsi V et al (2009) The Dukes staging system: a cornerstone in the clinical management of colorectal cancer. Lancet Oncol 10(11):1128CrossRefPubMed Haq AI, Schneeweiss J, Kalsi V et al (2009) The Dukes staging system: a cornerstone in the clinical management of colorectal cancer. Lancet Oncol 10(11):1128CrossRefPubMed
14.
go back to reference Becker DJ, Iyengar AD, Punekar SR et al (2020) Diabetes mellitus and colorectal carcinoma outcomes: a meta-analysis. Int J Colorectal Dis 35(11):1989–1999CrossRefPubMed Becker DJ, Iyengar AD, Punekar SR et al (2020) Diabetes mellitus and colorectal carcinoma outcomes: a meta-analysis. Int J Colorectal Dis 35(11):1989–1999CrossRefPubMed
15.
go back to reference Carethers JM, Jung BH (2015) Genetics and genetic biomarkers in sporadic colorectal cancer. Gastroenterology 149(5):1177–1190.e1173CrossRefPubMed Carethers JM, Jung BH (2015) Genetics and genetic biomarkers in sporadic colorectal cancer. Gastroenterology 149(5):1177–1190.e1173CrossRefPubMed
16.
go back to reference Mauri G, Sartore-Bianchi A, Russo AG et al (2019) Early-onset colorectal cancer in young individuals. Molec Oncol 13(2):109–131CrossRef Mauri G, Sartore-Bianchi A, Russo AG et al (2019) Early-onset colorectal cancer in young individuals. Molec Oncol 13(2):109–131CrossRef
17.
go back to reference Dienstmann R, Salazar R, Tabernero J (2018) Molecular subtypes and the evolution of treatment decisions in metastatic colorectal cancer. Am Soc Clin Oncol Educ Book 38:231–238CrossRefPubMed Dienstmann R, Salazar R, Tabernero J (2018) Molecular subtypes and the evolution of treatment decisions in metastatic colorectal cancer. Am Soc Clin Oncol Educ Book 38:231–238CrossRefPubMed
18.
go back to reference Sauerbrei W, Taube SE, McShane LM et al (2018) Reporting recommendations for tumor marker prognostic studies (REMARK): an abridged explanation and elaboration. J Natl Cancer Inst 110(8):803–811CrossRefPubMedPubMedCentral Sauerbrei W, Taube SE, McShane LM et al (2018) Reporting recommendations for tumor marker prognostic studies (REMARK): an abridged explanation and elaboration. J Natl Cancer Inst 110(8):803–811CrossRefPubMedPubMedCentral
19.
go back to reference Haninger DM, Kloecker GH, Bousamra Ii M et al (2014) Hepatoid adenocarcinoma of the lung: report of five cases and review of the literature. Mod Pathol 27(4):535–542CrossRefPubMed Haninger DM, Kloecker GH, Bousamra Ii M et al (2014) Hepatoid adenocarcinoma of the lung: report of five cases and review of the literature. Mod Pathol 27(4):535–542CrossRefPubMed
20.
go back to reference Kotowicz B, Fuksiewicz M, Jonska-Gmyrek J et al (2016) The assessment of the prognostic value of tumor markers and cytokines as SCCAg, CYFRA 21.1, IL-6, VEGF and sTNF receptors in patients with squamous cell cervical cancer, particularly with early stage of the disease. Tumour Biol 37(1):1271–1278CrossRefPubMed Kotowicz B, Fuksiewicz M, Jonska-Gmyrek J et al (2016) The assessment of the prognostic value of tumor markers and cytokines as SCCAg, CYFRA 21.1, IL-6, VEGF and sTNF receptors in patients with squamous cell cervical cancer, particularly with early stage of the disease. Tumour Biol 37(1):1271–1278CrossRefPubMed
21.
go back to reference Dolscheid-Pommerich RC, Manekeller S, Walgenbach-Brünagel G et al (2017) Clinical performance of CEA, CA19-9, CA15-3, CA125 and AFP in gastrointestinal cancer using LOCI™-based assays. Anticancer Res 37(1):353–359CrossRefPubMed Dolscheid-Pommerich RC, Manekeller S, Walgenbach-Brünagel G et al (2017) Clinical performance of CEA, CA19-9, CA15-3, CA125 and AFP in gastrointestinal cancer using LOCI™-based assays. Anticancer Res 37(1):353–359CrossRefPubMed
22.
go back to reference Gao Y, Wang J, Zhou Y et al (2018) Evaluation of serum CEA, CA19-9, CA72-4, CA125 and ferritin as diagnostic markers and factors of clinical parameters for colorectal cancer. Sci Rep 8(1):2732CrossRefPubMedPubMedCentral Gao Y, Wang J, Zhou Y et al (2018) Evaluation of serum CEA, CA19-9, CA72-4, CA125 and ferritin as diagnostic markers and factors of clinical parameters for colorectal cancer. Sci Rep 8(1):2732CrossRefPubMedPubMedCentral
23.
go back to reference Ge L, Pan B, Song F et al (2017) Comparing the diagnostic accuracy of five common tumour biomarkers and CA19-9 for pancreatic cancer: a protocol for a network meta-analysis of diagnostic test accuracy. BMJ Open 7(12):e018175CrossRefPubMedPubMedCentral Ge L, Pan B, Song F et al (2017) Comparing the diagnostic accuracy of five common tumour biomarkers and CA19-9 for pancreatic cancer: a protocol for a network meta-analysis of diagnostic test accuracy. BMJ Open 7(12):e018175CrossRefPubMedPubMedCentral
24.
go back to reference Muallem MZ, Sehouli J, Richter R et al (2020) Pre-operative serum CA125, peritoneal cancer index and intra-operative mapping score as predictors of surgical results in primary epithelial ovarian cancer. Int J Gynecol Cancer 30(1):62–66CrossRefPubMed Muallem MZ, Sehouli J, Richter R et al (2020) Pre-operative serum CA125, peritoneal cancer index and intra-operative mapping score as predictors of surgical results in primary epithelial ovarian cancer. Int J Gynecol Cancer 30(1):62–66CrossRefPubMed
25.
26.
go back to reference Sjoquist KM, Renfro LA, Simes RJ et al (2018) Personalizing survival predictions in advanced colorectal cancer: the ARCAD nomogram project. J Natl Cancer Inst 110(6):638–648CrossRefPubMed Sjoquist KM, Renfro LA, Simes RJ et al (2018) Personalizing survival predictions in advanced colorectal cancer: the ARCAD nomogram project. J Natl Cancer Inst 110(6):638–648CrossRefPubMed
27.
go back to reference Vacante M, Cristaldi E, Basile F et al (2019) Surgical approach and geriatric evaluation for elderly patients with colorectal cancer [J]. Updates Surg 71(3):411–417CrossRefPubMed Vacante M, Cristaldi E, Basile F et al (2019) Surgical approach and geriatric evaluation for elderly patients with colorectal cancer [J]. Updates Surg 71(3):411–417CrossRefPubMed
28.
go back to reference Ghiasloo M, Pavlenko D, Verhaeghe M et al (2020) Surgical treatment of stage IV colorectal cancer with synchronous liver metastases: a systematic review and network meta-analysis. Eur J Surg Oncol 46(7):1203–1213CrossRefPubMed Ghiasloo M, Pavlenko D, Verhaeghe M et al (2020) Surgical treatment of stage IV colorectal cancer with synchronous liver metastases: a systematic review and network meta-analysis. Eur J Surg Oncol 46(7):1203–1213CrossRefPubMed
29.
go back to reference Thomas DS, Fourkala EO, Apostolidou S, Gunu R, Ryan A, Jacobs I, Menon U, Alderton W, Gentry-Maharaj A, Timms JF (2015) Evaluation of serum CEA, CYFRA21-1 and CA125 for the early detection of colorectal cancer using longitudinal preclinical samples. Br J Cancer 113(2):268–274CrossRefPubMedPubMedCentral Thomas DS, Fourkala EO, Apostolidou S, Gunu R, Ryan A, Jacobs I, Menon U, Alderton W, Gentry-Maharaj A, Timms JF (2015) Evaluation of serum CEA, CYFRA21-1 and CA125 for the early detection of colorectal cancer using longitudinal preclinical samples. Br J Cancer 113(2):268–274CrossRefPubMedPubMedCentral
30.
go back to reference Luo H, Shen K, Li B et al (2020) Clinical significance and diagnostic value of serum NSE, CEA, CA19-9, CA125 and CA242 levels in colorectal cancer. Oncol Lett 20(1):742–750CrossRefPubMedPubMedCentral Luo H, Shen K, Li B et al (2020) Clinical significance and diagnostic value of serum NSE, CEA, CA19-9, CA125 and CA242 levels in colorectal cancer. Oncol Lett 20(1):742–750CrossRefPubMedPubMedCentral
31.
go back to reference Li Q, Dai W, Li Y et al (2017) Nomograms for predicting the prognostic value of serological tumor biomarkers in colorectal cancer patients after radical resection. Sci Rep 7(1):309 Li Q, Dai W, Li Y et al (2017) Nomograms for predicting the prognostic value of serological tumor biomarkers in colorectal cancer patients after radical resection. Sci Rep 7(1):309
Metadata
Title
Prognostic Nomogram for Colorectal Cancer Patients After Surgery
Authors
Pengqiang Zhong
Jiali Wu
Xingxing Yan
Yin Liu
Ruizhi Wang
Dong Wang
Publication date
16-02-2023
Publisher
Springer India
Published in
Indian Journal of Surgery / Issue 5/2023
Print ISSN: 0972-2068
Electronic ISSN: 0973-9793
DOI
https://doi.org/10.1007/s12262-023-03712-4

Other articles of this Issue 5/2023

Indian Journal of Surgery 5/2023 Go to the issue

Images in Surgery

Hidrocystoma on Forehead